Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- ;
- International Institute of Molecular and Cell Biology in Warsaw
- RMIT University
- Biobizkaia Health Research Institute
- Duke University
- Radboud University Medical Center (Radboudumc)
- University of Louisville
- University of Oslo
- Uppsala University
- ; University of Warwick
- Academic Europe
- Ilya Pharma
- Institute of Physical Chemistry, Polish Academy of Sciences
- Johannes Gutenberg University Mainz •
- Karolinska Institutet
- Leibniz
- Linköping University
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Munich
- University Medical Centre Groningen (UMCG)
- University of Basel
- University of British Columbia
- University of Florida
- University of Massachusetts Medical School
- University of Pittsburgh
- Université de Caen Normandie
- 17 more »
- « less
-
Field
-
at the Department of Biomedicine (“Cancer Immunology”) and PD Dr. Matter at the Department of Pathology are seeking a highly motivated PhD candidate with scientific interest in Cancer Immunology & Immunotherapy
-
. The Applied Immunology & Immunotherapy group is physically located at the Centre for Molecular Medicine, a translational medical centre, and the research focus is developing innovative ways to treat chronic
-
immunotherapies to fight diseases such as cancer. We are currently advertising a PhD position in this area (funded by an EPSRC DTP Studentship) in the Dept. of Chemistry at Warwick co-supervised by Dr Ann Dixon and
-
by an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description PhD researcher to work on the project "CAR-NK off the shelf 2.0: enhanced immunotherapy
-
and prospects for immunotherapy against relapsed or refractory haematological cancers. Phase I clinical trial to assess the feasibility and safety of allogeneic CD19-CAR-NK therapy for patients with
-
to impressive therapeutic effects, immunotherapies tend to take an increasingly important place in the treatment of many cancers such as lung or skin cancers. Immunotherapy consists of creating or strengthening a
-
urgent need to develop new treatment strategies. Immunotherapy has shown exciting promise for some solid tumours but has to date been ineffective for prostate cancer. Currently, it is unclear why prostate
-
a qualified Senior Researcher. This position will provide research training and experience in cellular immunology and tumor immunotherapy study. Previous training in immunology or biochemistry and
-
to study how the immune system can be harnessed to develop cancer immunotherapies. In particular, we are studying how oncolytic virotherapy can be used in synergy with immunotherapy to achieve optimal
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy